148 related articles for article (PubMed ID: 28005077)
1. Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2.
Ren Z; Aerts JL; Vandenplas H; Wang JA; Gorbenko O; Chen JP; Giron P; Heirman C; Goyvaerts C; Zacksenhaus E; Minden MD; Stambolic V; Breckpot K; De Grève J
Cell Death Dis; 2016 Dec; 7(12):e2560. PubMed ID: 28005077
[TBL] [Abstract][Full Text] [Related]
2. STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression.
Zhang Q; Wang HY; Liu X; Wasik MA
Nat Med; 2007 Nov; 13(11):1341-8. PubMed ID: 17922009
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity.
Zhou J; Kryczek I; Li S; Li X; Aguilar A; Wei S; Grove S; Vatan L; Yu J; Yan Y; Liao P; Lin H; Li J; Li G; Du W; Wang W; Lang X; Wang W; Wang S; Zou W
Nat Immunol; 2021 Apr; 22(4):460-470. PubMed ID: 33767425
[TBL] [Abstract][Full Text] [Related]
5. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
Fabbro M; Schuechner S; Au WW; Henderson BR
Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.
Sato K; Hayami R; Wu W; Nishikawa T; Nishikawa H; Okuda Y; Ogata H; Fukuda M; Ohta T
J Biol Chem; 2004 Jul; 279(30):30919-22. PubMed ID: 15184379
[TBL] [Abstract][Full Text] [Related]
7. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
Vega FM; Sevilla A; Lazo PA
Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
[TBL] [Abstract][Full Text] [Related]
8. BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase.
Feki A; Jefford CE; Berardi P; Wu JY; Cartier L; Krause KH; Irminger-Finger I
Oncogene; 2005 May; 24(23):3726-36. PubMed ID: 15782130
[TBL] [Abstract][Full Text] [Related]
9. A redox mechanism underlying nucleolar stress sensing by nucleophosmin.
Yang K; Wang M; Zhao Y; Sun X; Yang Y; Li X; Zhou A; Chu H; Zhou H; Xu J; Wu M; Yang J; Yi J
Nat Commun; 2016 Nov; 7():13599. PubMed ID: 27886181
[TBL] [Abstract][Full Text] [Related]
10. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.
Freund P; Kerenyi MA; Hager M; Wagner T; Wingelhofer B; Pham HTT; Elabd M; Han X; Valent P; Gouilleux F; Sexl V; Krämer OH; Groner B; Moriggl R
Leukemia; 2017 Oct; 31(10):2132-2142. PubMed ID: 28074064
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2.
Min SH; Kim DM; Heo YS; Kim HM; Kim IC; Yoo OJ
Life Sci; 2010 Jan; 86(1-2):66-72. PubMed ID: 19945467
[TBL] [Abstract][Full Text] [Related]
13. DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas.
Fukawa T; Ono M; Matsuo T; Uehara H; Miki T; Nakamura Y; Kanayama HO; Katagiri T
Cancer Res; 2012 Nov; 72(22):5867-77. PubMed ID: 23019224
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
Brodie KM; Henderson BR
Cell Signal; 2010 Feb; 22(2):291-302. PubMed ID: 19796682
[TBL] [Abstract][Full Text] [Related]
15. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
16. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
17. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
[TBL] [Abstract][Full Text] [Related]
18. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein activates E3 ubiquitin ligase Siah-1 to control virus propagation via a negative feedback loop.
Yeom S; Kim SS; Jeong H; Jang KL
J Gen Virol; 2017 Jul; 98(7):1774-1784. PubMed ID: 28714848
[TBL] [Abstract][Full Text] [Related]
20. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
